|Articles|November 12, 2018
SAS Adds Artificial Intelligence to Trial Data, RWE
Advertisement
SAS’ next-generation solutions for clinical trial data analysis and real world evidence debuted at PhUSE EU Connect in Frankfurt, Germany. This debut introduced SAS Life Science Analytics Framework and SAS Real World Evidence to help improve the development and safety of new pharmaceuticals with artificial intelligence.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Generative AI Transforms Clinical Study Report Development
September 16th 2025
- Operational Strategies That Strengthened the NIMBLE Trial Design
September 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares
2
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
3
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
4
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
5